--- title: "National Healthcare | 8-K: FY2026 Q2 Revenue: USD 408.03 M" type: "News" locale: "en" url: "https://longbridge.com/en/news/295568446.md" datetime: "2026-08-11T18:40:21.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295568446.md) - [en](https://longbridge.com/en/news/295568446.md) - [zh-HK](https://longbridge.com/zh-HK/news/295568446.md) generator: "portal-rs" --- # National Healthcare | 8-K: FY2026 Q2 Revenue: USD 408.03 M Revenue: As of FY2026 Q2, the actual value is USD 408.03 M. EPS: As of FY2026 Q2, the actual value is USD 2.54. EBIT: As of FY2026 Q2, the actual value is USD 48.92 M. ### Financial Performance for the Three Months Ended June 30 #### Net Operating Revenues National HealthCare Corporation reported net operating revenues of $408,025,000 for the second quarter of 2026, an 8.8% increase from $374,910,000 for the same period in 2025. Net Patient Revenues were $378,359,000 in Q2 2026 compared to $363,349,000 in Q2 2025. Other Revenues were $29,666,000 in Q2 2026 compared to $11,561,000 in Q2 2025. #### Net Income GAAP Net Income Attributable to National HealthCare Corporation was $40,319,000 for Q2 2026, up from $23,722,000 for Q2 2025. Non-GAAP Adjusted Net Income was $27,551,000 for Q2 2026, an increase of 7.2% from $25,710,000 for Q2 2025. #### Operational Costs and Profitability Income from Operations was $48,935,000 for Q2 2026, compared to $34,090,000 for Q2 2025. Total Costs and Expenses were $359,090,000 for Q2 2026, compared to $340,820,000 for Q2 2025. Salaries, Wages and Benefits were $241,902,000 in Q2 2026 compared to $226,534,000 in Q2 2025. Other Operating Expenses were $94,475,000 in Q2 2026 compared to $91,943,000 in Q2 2025. Facility Rent was $11,540,000 in Q2 2026 compared to $11,328,000 in Q2 2025. Depreciation and Amortization was $11,173,000 in Q2 2026 compared to $11,015,000 in Q2 2025. Non-operating Income was $4,172,000 in Q2 2026 compared to $5,132,000 in Q2 2025. Interest Expense was - $13,000 in Q2 2026 compared to - $1,993,000 in Q2 2025. Unrealized Gains on Marketable Equity Securities were $915,000 for Q2 2026 compared to - $5,061,000 in losses for Q2 2025. Income Tax Provision was - $13,472,000 in Q2 2026 compared to - $8,055,000 in Q2 2025. ### Financial Performance for the Six Months Ended June 30 #### Net Operating Revenues Total Net Operating Revenues were $789,846,000 for the six months ended June 30, 2026, compared to $748,607,000 for the same period in 2025. Net Patient Revenues were $748,164,000 for the six months ended June 30, 2026, compared to $724,956,000 for the same period in 2025. Other Revenues were $41,682,000 for the six months ended June 30, 2026, compared to $23,651,000 for the same period in 2025. #### Net Income GAAP Net Income Attributable to National HealthCare Corporation was $76,176,000 for the six months ended June 30, 2026, compared to $55,927,000 for the same period in 2025. Non-GAAP Adjusted Net Income was $57,640,000 for the six months ended June 30, 2026, compared to $50,549,000 for the same period in 2025. #### Operational Costs and Profitability Income from Operations was $81,188,000 for the six months ended June 30, 2026, compared to $64,857,000 for the same period in 2025. Total Costs and Expenses were $708,658,000 for the six months ended June 30, 2026, compared to $683,750,000 for the same period in 2025. Salaries, Wages and Benefits were $476,976,000 for the six months ended June 30, 2026, compared to $454,664,000 for the same period in 2025. Other Operating Expenses were $185,712,000 for the six months ended June 30, 2026, compared to $184,400,000 for the same period in 2025. Facility Rent was $23,183,000 for the six months ended June 30, 2026, compared to $22,693,000 for the same period in 2025. Depreciation and Amortization was $22,787,000 for the six months ended June 30, 2026, compared to $21,993,000 for the same period in 2025. Non-operating Income was $7,929,000 for the six months ended June 30, 2026, compared to $9,211,000 for the same period in 2025. Interest Expense was - $282,000 for the six months ended June 30, 2026, compared to - $4,099,000 for the same period in 2025. Unrealized Gains on Marketable Equity Securities were $9,989,000 for the six months ended June 30, 2026, compared to $5,921,000 for the same period in 2025. Income Tax Provision was - $22,184,000 for the six months ended June 30, 2026, compared to - $19,487,000 for the same period in 2025. ### Balance Sheet Data As of June 30, 2026, Cash, Cash Equivalents and Marketable Securities were $210,190,000, down from $255,801,000 as of December 31, 2025. Restricted Cash, Cash Equivalents and Marketable Securities were $151,833,000 as of June 30, 2026, compared to $159,848,000 as of December 31, 2025. Current Assets totaled $439,602,000 as of June 30, 2026, compared to $461,820,000 as of December 31, 2025. Property and Equipment, Net, increased to $726,768,000 as of June 30, 2026, from $673,797,000 as of December 31, 2025. Total Assets were $1,536,930,000 as of June 30, 2026, compared to $1,526,419,000 as of December 31, 2025. Current Liabilities were $236,112,000 as of June 30, 2026, compared to $246,132,000 as of December 31, 2025. Current and Long-term Debt decreased to $0 as of June 30, 2026, from $40,000,000 as of December 31, 2025. National HealthCare Corporation Stockholders’ Equity increased to $1,122,302,000 as of June 30, 2026, from $1,068,772,000 as of December 31, 2025. ### Selected Operating Statistics (Skilled Nursing) #### Skilled Nursing Per Diems (Three Months Ended June 30) The Average Skilled Nursing Per Diem was $366.88 in Q2 2026 compared to $361.42 in Q2 2025. Specifically, Medicare per diem was $628.12 (2026) vs. $614.85 (2025), Managed Care was $500.15 (2026) vs. $486.17 (2025), Medicaid was $290.12 (2026) vs. $286.43 (2025), and Private Pay and Other was $351.83 (2026) vs. $341.34 (2025). #### Skilled Nursing Per Diems (Six Months Ended June 30) The Average Skilled Nursing Per Diem was $369.24 for the six months ended June 30, 2026, compared to $360.78 for the same period in 2025. Medicare per diem was $629.32 (2026) vs. $613.47 (2025), Managed Care was $503.52 (2026) vs. $489.30 (2025), Medicaid was $291.15 (2026) vs. $284.07 (2025), and Private Pay and Other was $350.90 (2026) vs. $339.24 (2025). #### Skilled Nursing Patient Days (Three Months Ended June 30) Total Skilled Nursing Patient Days were 749,723 in Q2 2026 compared to 729,519 in Q2 2025. Medicare patient days were 78,137 (2026) vs. 83,615 (2025), Managed Care were 87,782 (2026) vs. 83,015 (2025), Medicaid were 378,010 (2026) vs. 368,687 (2025), and Private Pay and Other were 205,794 (2026) vs. 194,202 (2025). #### Skilled Nursing Patient Days (Six Months Ended June 30) Total Skilled Nursing Patient Days were 1,474,179 for the six months ended June 30, 2026, compared to 1,447,655 for the same period in 2025. Medicare patient days were 162,177 (2026) vs. 169,869 (2025), Managed Care were 171,158 (2026) vs. 166,661 (2025), Medicaid were 740,303 (2026) vs. 732,329 (2025), and Private Pay and Other were 400,541 (2026) vs. 378,796 (2025). ### Outlook/Guidance National HealthCare Corporation advises investors that any forward-looking statements are subject to risks and uncertainties and do not guarantee future performance. These risks are thoroughly detailed in the company’s SEC filings, including Forms 8-K, 10-Q, and 10-K. ### Related Stocks - [NHC.US](https://longbridge.com/en/quote/NHC.US.md) ## Related News & Research - [National Healthcare Senior VP, CIO Ben Anderson Flatt sells $1.59 million in common shares](https://longbridge.com/en/news/297824014.md) - [National Healthcare director David R. Gifford sells 1,779 shares worth $400,222.18](https://longbridge.com/en/news/297368380.md) - [REG - BlackRock Group Adv Medical Solutns. - Form 8.3 - Advanced Medical Solutions Group plc](https://longbridge.com/en/news/297800407.md) - [REG - Verition Fund Mgmt Spire Healthcare Grp - Form 8.3 - SPIRE HEALTHCARE GROUP PLC](https://longbridge.com/en/news/297798360.md) - [Worldwide Healthcare Trust estimates Sept. 1 NAV at 414.74p per share (cum income)](https://longbridge.com/en/news/297798173.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**